Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive
{{output}}
Tumors of mesenchymal and epithelial origin produce IGF-2, which activates pathways in the tumors. In a minority of patients, the tumors (hepatomas, fibromas, and fibrosarcomas are the most common among many) release into the circulation enough IGF-2-related p... ...